scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Graziano Pinna | Q87954226 |
P2093 | author name string | Alessandro Guidotti | |
Erminio Costa | |||
P2860 | cites work | Does neurosteroid modulatory efficacy depend on GABAA receptor subunit composition? | Q41586535 |
On the putative physiological role of allopregnanolone on GABA(A) receptor function | Q42693899 | ||
Cerebral benzodiazepine receptors in depressed patients measured with [123I]iomazenil SPECT. | Q44612591 | ||
Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat. | Q44748223 | ||
Permissive role of brain allopregnanolone content in the regulation of pentobarbital-induced righting reflex loss | Q48148744 | ||
Behavioural neuroscience: The circuit of fear. | Q48328707 | ||
Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnanolone) availability? | Q48355449 | ||
Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder | Q48667447 | ||
Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor function in rat brain | Q48886515 | ||
Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. | Q51601652 | ||
The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5α-dihydroprogesterone in psychiatric disorders | Q59486481 | ||
The role of the medial prefrontal cortex-amygdala circuit in stress effects on the extinction of fear | Q21342971 | ||
Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation | Q24595197 | ||
Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes | Q24648866 | ||
Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis | Q24676534 | ||
Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine | Q24685198 | ||
Emotion circuits in the brain | Q27860733 | ||
Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress | Q28241720 | ||
Neurosteroids: endogenous regulators of the GABA(A) receptor | Q28256904 | ||
Neurosteroid access to the GABAA receptor | Q28286885 | ||
New approaches to antidepressant drug discovery: beyond monoamines | Q28293089 | ||
Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake | Q28293369 | ||
Brain allopregnanolone regulates the potency of the GABAA receptor agonist muscimol | Q29541102 | ||
Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder | Q30493113 | ||
Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives | Q33707601 | ||
GABA(A)R plasticity during pregnancy: relevance to postpartum depression | Q33872187 | ||
Neurosteroids act on recombinant human GABAA receptors | Q34187011 | ||
The amygdaloid complex: anatomy and physiology. | Q34211730 | ||
Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice | Q34713732 | ||
In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine | Q34763151 | ||
Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice. | Q34778055 | ||
Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders | Q35683247 | ||
From monoamines to genomic targets: a paradigm shift for drug discovery in depression | Q35709598 | ||
Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action | Q36297266 | ||
Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research--past, present, and future | Q36571175 | ||
Neural mechanisms of aggression | Q36856434 | ||
Neurosteroid modulation of GABAA receptors: molecular determinants and significance in health and disease | Q37022533 | ||
Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography | Q37243720 | ||
Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids | Q37647632 | ||
A role for the human dorsal anterior cingulate cortex in fear expression | Q40182257 | ||
Benzodiazepines on trial: a research strategy for their rehabilitation | Q41008175 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | drug discovery | Q1418791 |
P304 | page(s) | 24-30 | |
P577 | publication date | 2009-02-01 | |
P1433 | published in | Current Opinion in Pharmacology | Q3007702 |
P1476 | title | SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake | |
P478 | volume | 9 |